CCK-B receptor antagonist YF476 inhibits pancreatic enzyme secretion at a duodenal level in pigs

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 9, 2004, Pages 886-890

  Evilevitch, L ^a   Westrom B R ^a   Pierzynowski, S G ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

CCK receptors; Entero pancreatic reflex; Exocrine pancreas; Pig; Trypsin

Indexed keywords

1 [2,3 DIHYDRO 2 OXO 1 PIVALOYLMETHYL 5 (2 PYRIDYL) 1H 1,4 BENZODIAZEPIN 3 YL] 3 [3 (METHYLAMINO)PHENYL]UREA; AMYLASE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR; PANCREAS ENZYME; TRYPSIN;

ANIMAL EXPERIMENT; ARTICLE; CHOLECYSTOKININ BLOOD LEVEL; CONTROLLED STUDY; DUODENUM; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME RELEASE; HORMONAL REGULATION; JUGULAR VEIN; NONHUMAN; PANCREAS; PANCREAS DUCT; PANCREAS JUICE; PANCREAS SECRETION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH; STOMACH BLOOD FLOW; SWINE;

ANIMALS; BENZODIAZEPINONES; DOSE-RESPONSE RELATIONSHIP, DRUG; DUODENUM; FEMALE; INFUSIONS, INTRAVENOUS; MALE; MODELS, ANIMAL; PANCREATIC EXTRACTS; PANCREATIN; PANCRELIPASE; PHENYLUREA COMPOUNDS; PROBABILITY; RECEPTOR, CHOLECYSTOKININ B; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SWINE;

EID: 4544290724     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410006242     Document Type: Article

References (23)

1. Williams JA. Cholecystokinin: a hormone and a neurotransmitter. Biomed Res 1982;3:107-21.
2. Lilja P, Wiener I, Inoue K, Fried GM, Greeley GH, Jr, Thompson JC. Release of cholecystokinin in response to food and intraduodenal fat in pigs, dogs and man. Surg Gynecol Obstet 1984;159:557-61.
3. Owyang C. Physiological mechanisms of cholecystokinin action on pancreatic secretion. Am J Physiol 1996;271:G1-7.
4. Cuber JC, Corring T, Levenez F, Bernard C, Chayvialle JA. Effects of cholecystokinin octapeptide on the pancreatic exocrine secretion in the pig. Can J Physiol Pharmacol 1989;67:1391-7.
5. Pierzynowski SG, Märtensson H, Weström B, Ahrén B, Uvnås-Möberg K, Karlsson B. Cholecystokinin (CCK-33) can stimulates pancreatic secretion by a local intestinal mechanism in the pig. Biomed Res 1993;14:217-21.
6. Kiela P, Zabielski R, Podgurniak P, Midura M, Barej W, Gregory P, et al. Cholecystokinin-8 and vasoactive intestinal polypeptide stimulate exocrine pancreatic secretion via duodenally mediated mechanisms in the conscious pig. Exp Physiol 1996;81:375-84.
7. Evilevitch L, Westrom BR, Pierzynowski SG. CCK regulates pancreatic enzyme secretion via short duodenal-pancreatic reflexes in pigs. Scand J Gastroenterol 2003;38:201-6.
8. Wank SA. Cholecystokinin receptors. Am J Physiol Gastrointest Liver Physiol 1995;269:G628-G46.
9. Philippe C, Lhoste EF, Dufresne M, Moroder L, Corring T, Fourmy D. Pharmacological and biochemical evidence for the simultaneous expression of CCKB/gastrin and CCKA receptors in the pig pancreas. Br J Pharmacol 1997;120:447-54.
10. Morisset J, Wong H, Walsh JH, Laine J, Bourassa J. Pancreatic CCK(B) receptors: their potential roles in somatostatin release and delta-cell proliferation. Am J Physiol Gastrointest Liver Physiol 2000;279:G148-56.
11. Morisset J, Levenez F, Corring T, Benrezzak O, Pelletier G, Calvo E. Pig pancreatic acinar cells possess predominantly the CCK-B receptor subtype. Am J Physiol 1996;271:E397-402.
12. Radberg K, Botermans J, Westrom BR, Pierzynowski SG. Depressive effects of anaesthesia or sedation on exocrine pancreatic function in pigs. Lab Anim Sci 1999;49:662-4.
13. Nishida A, Miyata K, Tsutsumi R, Yuki H, Akuzawa S, Kobayashi A, et al. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2′-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo. J Pharmacol Exp Ther 1994;269:725-31.
14. Semple G, Ryder H, Rooker DP, Batt AR, Kendrick DA, Szelke M, et al. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1, 4-benzodiazepin-3-yl)-N′-(3-(methyl-amino)phenyl)urea (YF476): a potent and orally active gastrin/ CCK-B antagonist. J Med Chem 1997;40:331-41.
15. Takinami Y, Yuki H, Nishida A, Akuzawa S, Uchida A, Takemoto Y, et al. YF476 is a new potent and selective gastrin/ cholecystokinin-B receptor antagonist in vitro and in vivo. Aliment Pharmacol Ther 1997;11:113-20.
16. Ding XQ, Lindstrom E, Hakanson R. Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity. Pharmacol Toxicol 1997;81:232-7.
17. Kitano M, Norlen P, Ding X-Q, Nakamura S, Håkanson R. Long-lasting cholecystokinin-2 receptor blockade after a single subcutaneous injection of YF476 or YM022. Br J Pharmacol 2000;130:699-705.
18. Lowry OH NJR, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
19. Morisset J, Julien S, Laine J. Localization of cholecystokinin receptor subtypes in the endocrine pancreas. J Histochem Cytochem 2003;51:1501-13.
20. Schweiger M, Erhard MH, Amselgruber WM. Cell-specific localization of the cholecystokininA receptor in the porcine pancreas. Anat Histol Embryol 2000;29:357-61.
21. Blackshaw LA, Grundy D. Responses of vagal efferent fibres to stimulation of gastric mechano- and chemoreceptors in the anaesthetized ferret. J Auton Nerv Syst 1989;27:39-45.
22. Blackshaw LA, Grundy D. Effects of cholecystokinin (CCK-8) on two classes of gastroduodenal vagal afferent fibre. J Auton Nerv Syst 1990;31:191-201.
23. Wank A. Brain and gastrointestinal cholecystokinin receptor family; structure and functional expression. Proc Natl Acad Sci USA 1992;89:8691-5.